These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 3069729)

  • 1. Structure and expression of the ret transforming gene.
    Takahashi M
    IARC Sci Publ; 1988; (92):189-97. PubMed ID: 3069729
    [No Abstract]   [Full Text] [Related]  

  • 2. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
    Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
    J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
    Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
    Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and characterization of human ret-II oncogene.
    Ishizaka Y; Tahira T; Ochiai M; Ikeda I; Sugimura T; Nagao M
    Oncogene Res; 1988 Sep; 3(2):193-7. PubMed ID: 3226727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG.
    Funabiki T; Kreider BL; Ihle JN
    Oncogene; 1994 Jun; 9(6):1575-81. PubMed ID: 8183551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oncogenes and DNA diagnosis].
    Nihon Rinsho; 1989 May; 47 Suppl():579-734. PubMed ID: 2640252
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression cDNA cloning of a serine kinase transforming gene.
    Chan AM; Chedid M; McGovern ES; Popescu NC; Miki T; Aaronson SA
    Oncogene; 1993 May; 8(5):1329-33. PubMed ID: 8479752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenes and anti-oncogenes in human central nervous system tumors.
    Batra SK; Rasheed BK; Bigner SH; Bigner DD
    Lab Invest; 1994 Nov; 71(5):621-37. PubMed ID: 7967518
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomas.
    Nikiforov YE; Koshoffer A; Nikiforova M; Stringer J; Fagin JA
    Oncogene; 1999 Nov; 18(46):6330-4. PubMed ID: 10597232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the breakpoint regions of ELE1 and RET genes involved in the generation of RET/PTC3 oncogene in sporadic and in radiation-associated papillary thyroid carcinomas.
    Bongarzone I; Butti MG; Fugazzola L; Pacini F; Pinchera A; Vorontsova TV; Demidchik EP; Pierotti MA
    Genomics; 1997 Jun; 42(2):252-9. PubMed ID: 9192845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transforming gene, hst.
    Terada M; Sakamoto H; Yoshida T; Miyagawa K; Sugimura T
    IARC Sci Publ; 1988; (92):133-8. PubMed ID: 3235153
    [No Abstract]   [Full Text] [Related]  

  • 12. Developmental expression of the RET protooncogene.
    Avantaggiato V; Dathan NA; Grieco M; Fabien N; Lazzaro D; Fusco A; Simeone A; Santoro M
    Cell Growth Differ; 1994 Mar; 5(3):305-11. PubMed ID: 8018563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ret gene from a human stomach cancer].
    Koda T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):913-24. PubMed ID: 3248771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms involved in human B and T cell neoplasia.
    Croce CM; Tsujimoto Y; Nowell PC
    Gene Amplif Anal; 1986; 4():143-60. PubMed ID: 3146545
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure and mechanism of activation of the myb oncogene.
    Rosson D; Reddy EP
    Gene Amplif Anal; 1986; 4():99-108. PubMed ID: 3333363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide sequence of chicken c-myb complementary DNA and implications for myb oncogene activation.
    Rosson D; Reddy EP
    Nature; 1986 Feb 13-19; 319(6054):604-6. PubMed ID: 3753748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression cDNA cloning of a novel oncogene with sequence similarity to regulators of small GTP-binding proteins.
    Chan AM; McGovern ES; Catalano G; Fleming TP; Miki T
    Oncogene; 1994 Apr; 9(4):1057-63. PubMed ID: 8134109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
    Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
    Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
    Katzav S
    Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.